Li H, Bao X, Xiao Y, Cao F, Han X, Zhao Y
Transl Cancer Res. 2024; 13(1):217-230.
PMID: 38410221
PMC: 10894342.
DOI: 10.21037/tcr-23-1254.
Lazarevic M, Jovanovic N, Cvetkovic V, Tosic S, Vitorovic J, Stamenkovic S
Diagnostics (Basel). 2023; 13(3).
PMID: 36766464
PMC: 9914267.
DOI: 10.3390/diagnostics13030360.
Wu B, Dou G, Zhang Y, Wang J, Wang X, Jiang S
Exp Ther Med. 2022; 23(3):217.
PMID: 35126720
PMC: 8796280.
DOI: 10.3892/etm.2022.11141.
Penketh P, Williamson H, Baumann R, Shyam K
Molecules. 2021; 26(2).
PMID: 33419160
PMC: 7825511.
DOI: 10.3390/molecules26020259.
Penketh P, Williamson H, Shyam K
Curr Drug Deliv. 2020; 17(5):362-374.
PMID: 32342817
PMC: 7499353.
DOI: 10.2174/1567201817666200427215044.
Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
Vaidya M, Bacchus M, Sugaya K
PLoS One. 2018; 13(5):e0197782.
PMID: 29787607
PMC: 5963750.
DOI: 10.1371/journal.pone.0197782.
-methylguanine-induced transcriptional mutagenesis reduces p53 tumor-suppressor function.
Ezerskyte M, Paredes J, Malvezzi S, Burns J, Margison G, Olsson M
Proc Natl Acad Sci U S A. 2018; 115(18):4731-4736.
PMID: 29666243
PMC: 5939098.
DOI: 10.1073/pnas.1721764115.
Overexpression of AGT promotes bronchopulmonary dysplasis via the JAK/STAT signal pathway.
Shen L, Zhang T, Lu H
Oncotarget. 2017; 8(56):96079-96088.
PMID: 29221188
PMC: 5707082.
DOI: 10.18632/oncotarget.21712.
Is the prognostic significance of O6-methylguanine- DNA methyltransferase promoter methylation equally important in glioblastomas of patients from different continents? A systematic review with meta-analysis.
Meng W, Jiang Y, Ma J
Cancer Manag Res. 2017; 9:411-425.
PMID: 29033608
PMC: 5614747.
DOI: 10.2147/CMAR.S140447.
Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
Liang B, Li C, Zhao J
Med Oncol. 2016; 33(10):111.
PMID: 27581154
DOI: 10.1007/s12032-016-0829-6.
Genetic Association Between Angiotensinogen Polymorphisms and Lung Cancer Risk.
Wang H, Zhang K, Qin H, Yang L, Zhang L, Cao Y
Medicine (Baltimore). 2015; 94(37):e1250.
PMID: 26376373
PMC: 4635787.
DOI: 10.1097/MD.0000000000001250.
Immunohistochemical Assessment of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and Its Relationship with p53 Expression in Endometrial Cancers.
Lee K
J Cancer Prev. 2014; 18(4):351-4.
PMID: 25337565
PMC: 4189440.
DOI: 10.15430/jcp.2013.18.4.351.
MGMT Leu84Phe polymorphism contributes to cancer susceptibility: evidence from 44 case-control studies.
Liu J, Zhang R, Chen F, Yu C, Sun Y, Jia C
PLoS One. 2013; 8(9):e75367.
PMID: 24086516
PMC: 3784571.
DOI: 10.1371/journal.pone.0075367.
Association between MGMT promoter methylation and non-small cell lung cancer: a meta-analysis.
Gu C, Lu J, Cui T, Lu C, Shi H, Xu W
PLoS One. 2013; 8(9):e72633.
PMID: 24086261
PMC: 3784462.
DOI: 10.1371/journal.pone.0072633.
The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis.
Zhang K, Wang X, Zhou B, Zhang L
Fam Cancer. 2013; 12(3):449-58.
PMID: 23397067
DOI: 10.1007/s10689-013-9607-1.
Metronomic treatment of temozolomide increases anti-angiogenicity accompanied by down-regulated O(6)-methylguanine-DNA methyltransferase expression in endothelial cells.
Ko K, Lee E, Joe Y, Hong Y
Exp Ther Med. 2012; 2(2):343-348.
PMID: 22977508
PMC: 3440646.
DOI: 10.3892/etm.2011.207.
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?.
Combs S, Rieken S, Wick W, Abdollahi A, von Deimling A, Debus J
Radiat Oncol. 2011; 6:115.
PMID: 21910919
PMC: 3199258.
DOI: 10.1186/1748-717X-6-115.
Absence of the MGMT protein as well as methylation of the MGMT promoter predict the sensitivity for temozolomide.
van Nifterik K, van den Berg J, van der Meide W, Ameziane N, Wedekind L, Steenbergen R
Br J Cancer. 2010; 103(1):29-35.
PMID: 20517307
PMC: 2905289.
DOI: 10.1038/sj.bjc.6605712.
p53-Mediated down-regulation of the human DNA repair gene O6-methylguanine-DNA methyltransferase (MGMT) via interaction with Sp1 transcription factor.
Bocangel D, Sengupta S, Mitra S, Bhakat K
Anticancer Res. 2009; 29(10):3741-50.
PMID: 19846904
PMC: 2814523.
O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib.
Watson A, Middleton M, McGown G, Thorncroft M, Ranson M, Hersey P
Br J Cancer. 2009; 100(8):1250-6.
PMID: 19367283
PMC: 2676560.
DOI: 10.1038/sj.bjc.6605015.